Mitchell Finer

Directeur/Membre du Conseil chez PEPGEN INC. Fortune : - $ au 31/08/2026

Profil

Mitchell H.
Finer founded Cell Genesys, Inc. in 1989, where he worked as Vice President-Research from 1989 to 1999, Adverum Biotechnologies, Inc. in 2006, where he worked as Director from 2006 to 2019, Oncorus, Inc. in 2015, where he worked as Director in 2023, ElevateBio LLC in 2017, where he worked as Director, President-Research & Development from 2017 to 2024, and CODA Biotherapeutics, Inc. in 2014, where he worked as Director from 2014 to 2022.
Dr. Finer also founded Abgenix, Inc., where he worked as Principal.
Dr. Finer also currently works at Abata Therapeutics, Inc., as Director, Tabby Therapeutics Ltd., as Director, and PepGen Inc., as Independent Non-Executive Director from 2025.
Dr. Finer also formerly worked at Intracel Corp., as Chief Executive Officer from 2005 to 2007, Genteric, Inc., as President & Chief Executive Officer from 2003 to 2005, Intracel Resources LLC, as Chief Executive Officer, Intracel Holdings Corp., as Chief Executive Officer from 2005 to 2008, LifeEDIT Therapeutics, Inc., as Chief Executive Officer, MPM BioImpact LLC, as Managing Director, Candel Therapeutics, Inc., as Director, TCR² Therapeutics, Inc., as Independent Director from 2015 to 2020, Semma Therapeutics, Inc., as Director, Turmeric Acquisition Corp., as Independent Director, SaviCorp, as Vice President-Research & Development, ViaCyte, Inc., as Senior Vice President-Development from 2008 to 2010, Aventis Pharmaceuticals, Inc., as Vice President-Gencell Division from 1999 to 2002, Sanofi India Ltd., as Vice President-Research, Genetix Biotherapeutics, Inc., as Chief Scientific Officer from 2010 to 2015, and Elevatebio Base Camp, Inc., as President from 2019 to 2021.
Dr. Finer received his doctorate degree in 1986 from Harvard University and undergraduate degree in 1979 from the University of California, Berkeley.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
PEPGEN INC. -.--%	18/06/2026	0 ( -.--% )	- $	31/08/2026

Postes actifs de Mitchell Finer

Sociétés	Poste	Début
PEPGEN INC.	Directeur/Membre du Conseil	27/03/2025
Tabby Therapeutics Ltd.	Directeur/Membre du Conseil	-
Abata Therapeutics, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Mitchell Finer

Sociétés	Poste	Fin
ElevateBio LLC	Fondateur	01/05/2024
ONCORUS, INC.	Directeur Général	01/07/2018
CODA Biotherapeutics, Inc.	Fondateur	01/10/2022
Elevatebio Base Camp, Inc.	President	01/12/2021
TCR2 THERAPEUTICS INC.	Directeur/Membre du Conseil	04/05/2020